Four disciplines. One integrated market-entry plan.
Engage a single service or a coordinated programme. One founder leads your engagement, with delivery scope, schedule and language support agreed before work begins.
Chart the right route to approval, either side.
We assess EU and FDA pathways against your product and evidence, prepare briefing documents and meeting rehearsals, and coordinate CTA / IND or marketing dossier preparation within the agreed scope.
- EU and FDA regulatory strategy and procedure selection
- Scientific advice, pre-submission and notified-body meetings
- CTA / IND dossiers, CTD/eCTD and technical documentation requirements
- Lifecycle management, variations and post-approval commitments
Run European and US studies with confidence.
We review endpoints, comparators, country and site options, evidence needs and budget trade-offs for the intended EU or FDA pathway. Clinical start-up is coordinated with Regulatory Affairs, which leads application preparation and submission.
- EU and US clinical development planning and protocol review
- Study start-up, ethics and data-protection coordination
- CRO and vendor selection, contracting and oversight
- Site feasibility, study management and GCP quality oversight
Build quality into development from the start.
We assess applicable quality requirements, support investigations and CAPA effectiveness, and prepare manufacturing teams for inspections through training and practical gap closure.
- QMS design, gap assessment and implementation
- Mock inspections, audit readiness and CAPA management
- Supplier, CDMO and distributor qualification
- Specialist-role requirements and appointment planning
Turn evidence into adoption.
Evidence planning begins before launch. We assess clinical, scientific and payer questions alongside the development strategy, identifying the evidence gaps and specialist support needed for the next stage.
- Medical strategy, evidence-generation and launch planning
- Clinical and payer evidence-gap assessment
- Scientific communication and publication planning
- Post-market evidence and specialist support requirements
Clear scope, senior delivery, knowledge transferred.
Scope
A diagnostic conversation and document review to understand your starting point and the requirements of your target EU or US pathway.
Plan
A sequenced roadmap with agreed milestones, deliverables, budget assumptions and one accountable founder as lead.
Deliver
Remote delivery, with on-site visits by arrangement. Reporting and language support are agreed for each engagement.
Transfer
Templates, training and documentation handed over so your team grows more capable with every engagement.
Market-entry assessment
Start with an assessment of your pathway, evidence gaps and indicative budget for the EU and/or US. Scope and schedule agreed per engagement.
The route your product qualifies for in each market, and what it commits you to.
What your existing data supports, what needs justification, and what has to be generated.
An indicative range for the programme, with the assumptions written down.
Available for Pharma, Biotech and Medical devices & IVD.
Book an introductory callStart where it makes sense for you.
Advisory sprint
A focused assessment of a defined question: pathway, evidence gaps, feasibility or audit readiness. Scope and schedule agreed per engagement.
Project delivery
A defined deliverable executed end to end: a dossier, a CTIS submission, a QMS implementation or a medical launch plan.
Programme partnership
One founder coordinates the agreed workstreams and milestones. Specialist delivery arrangements are confirmed before the programme begins.
Not sure which service you need first?
Most clients don't. A short conversation is usually enough to identify the critical path.
We aim to reply within two working days. Language support is agreed for each engagement.
